GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Κατάταξη σε μετοχές #3775
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Τιμή μετοχής
$25.73
Κεφαλαιοποίηση
$4.36B
Αλλαγή (1 ημέρα)
-5.33%
Αλλαγή (1 έτος)
-17.92%
Χώρα
IN
Εμπόριο GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Κατηγορία

Healthcare
Ιστορικό τιμής μετοχής για την GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Υψηλότερη τιμή κλεισίματος: $28.33 στις 2026-10-01

Χαμηλότερη τιμή κλεισίματος: $7.46 στις 1999-01-01
Ιστορικό τιμής μετοχής της GlaxoSmithKline Pharmaceuticals Limited από 1999 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -0.80%
2025 3.53%
2024 30.13%
2023 28.84%
2022 -31.26%
2021 11.05%
2020 -8.11%
2019 15.01%
2018 5.68%
2017 -5.61%
2016 -18.58%
2015 0.11%
2014 11.37%
2013 16.93%
2012 5.11%
2011 -25.99%
2010 39.42%
2009 47.96%
2008 -8.92%
2007 -0.02%
2006 7.37%
2005 41.03%
2004 38.71%
2003 85.99%
2002 3.08%
2001 -33.62%
2000 -42.61%
1999 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$1.31K 61.37%
US
$268.68 39.25%
US
$285.11 24.67%
US
$149.12 70.20%
US
$482.01 30.76%
CH